These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9741396)

  • 21. An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats.
    Winn SR; Wahlberg L; Tresco PA; Aebischer P
    Exp Neurol; 1989 Sep; 105(3):244-50. PubMed ID: 2504616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
    Hamaue N; Ogata A; Terado M; Tsuchida S; Yabe I; Sasaki H; Hirafuji M; Togashi H; Aoki T
    Brain Res; 2010 Jan; 1309():110-5. PubMed ID: 19879254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related differences in the spontaneous and thyrotropin-releasing hormone-stimulated release of prolactin and thyrotropin in ovariectomized rats.
    Wang PS; Liu JY; Hwang CY; Hwang C; Day CH; Chang CH; Pu HF; Pan JT
    Neuroendocrinology; 1989 Jun; 49(6):592-6. PubMed ID: 2505153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats.
    Miyamoto M; Nagawa Y
    Eur J Pharmacol; 1977 Jul; 44(2):143-52. PubMed ID: 407089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraventricular administration of thyrotrophin-releasing hormone (TRH) suppresses prolactin secretion and synthesis: a possible involvement of dopamine release by TRH from rat hypothalamus.
    Ikegami H; Jikihara H; Koike K; Morishige K; Kurachi H; Yamamoto N; Hirota K; Miyake A; Tanizawa O
    J Endocrinol; 1992 Apr; 133(1):59-66. PubMed ID: 1355520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS.
    Ogawa N; Mizuno S; Nukina I; Tsukamoto S; Mori A
    Brain Res; 1983 Mar; 263(2):348-50. PubMed ID: 6301651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulating and inhibiting effects of thyrotropin-releasing hormone on growth hormone release in rats.
    Chihara K; Kato Y; Ohgo S; Iwasaki Y; Abe H; Maeda K; Imura H
    Endocrinology; 1976 Apr; 98(4):1047-53. PubMed ID: 819245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semicircadian rhythm of dopamine release in the mediobasal hypothalamus in awake rats during pseudopregnancy: evidence that a thyrotropin-releasing hormone analogue stimulates dopamine release and thereby inhibits prolactin secretion.
    Timmerman W; Poelman RT; Westerink BH; Schuiling GA
    Neuroendocrinology; 1995 Nov; 62(5):434-43. PubMed ID: 8559275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
    Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K
    Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of thyrotropin-releasing hormone and cyclo-histidine-proline on the homeothermic development of neonatal rats.
    Sato T; Kato T; Miyamori C; Kajiwara S; Murata A; Imura E; Sakura N; Hashimoto T
    Acta Endocrinol (Copenh); 1986 Oct; 113(2):181-8. PubMed ID: 3096034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo evaluation by differential pulse voltammetry of the effect of thyrotropin-releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat.
    Crespi F; Keane PE; Morre M
    Exp Brain Res; 1986; 62(2):329-34. PubMed ID: 2423357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic administration of thyrotropin-releasing hormone enhances striatal dopamine release in vivo.
    Kreutz MR; Acworth IN; Lehnert H; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):347-52. PubMed ID: 1707722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis.
    Giovannini MG; Casamenti F; Nistri A; Paoli F; Pepeu G
    Br J Pharmacol; 1991 Feb; 102(2):363-8. PubMed ID: 1901747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone.
    Martinez de la Escalera G; Weiner RI
    Neuroendocrinology; 1988 Mar; 47(3):186-93. PubMed ID: 3129665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.
    Dominguez-Meijide A; Villar-Cheda B; Garrido-Gil P; Sierrra-Paredes G; Guerra MJ; Labandeira-Garcia JL
    Neuropharmacology; 2014 Jan; 76 Pt A():156-68. PubMed ID: 23973568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic neuronal systems modulate the central cardiovascular effects of TRH in rats.
    Jedrusiak J; Brus R; Kostrzewa RM; Słowiński Z
    Pol J Pharmacol; 1995; 47(1):43-52. PubMed ID: 7550548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hypothalamic dopamine on growth hormone-releasing hormone-induced growth hormone secretion and thyrotropin-releasing hormone-induced prolactin secretion in goats.
    Jin J; Hashizume T
    Anim Sci J; 2015 Jun; 86(6):634-40. PubMed ID: 25442325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyrotropin-releasing hormone d,l polylactide nanoparticles (TRH-NPs) protect against glutamate toxicity in vitro and kindling development in vivo.
    Veronesi MC; Aldouby Y; Domb AJ; Kubek MJ
    Brain Res; 2009 Dec; 1303():151-60. PubMed ID: 19766611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-dependent effects of oral thyrotropin-releasing hormone in hyperthyroid female rats.
    Iglesias R; Llobera M; Montoya E
    Horm Metab Res; 1986 Jul; 18(7):454-6. PubMed ID: 3091472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of extracerebral dopamine on salsolinol- or thyrotropin-releasing hormone-induced prolactin (PRL) secretion in goats.
    Inaba Y; Kato Y; Itou A; Chiba A; Sawai K; Fülöp F; Nagy GM; Hashizume T
    Anim Sci J; 2016 Dec; 87(12):1522-1527. PubMed ID: 26997651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.